🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — March 2026

Pancreatitis risk assessment — March 2026

sarah.morrison Fri, Mar 6, 2026 at 3:33 AM 9 replies 740 viewsPage 1 of 2
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Mar 6, 2026 at 3:33 AM#1

My prescriber mentioned this once, in a list, at speed, and I have been unable to find out since how worried I am supposed to be.

What I actually want to know is what the pooled safety data actually shows for this class, as opposed to what the label warning implies.

I would rather have one careful answer than five confident ones.

45 15josh_phd_bmore, roxy_nash, tony_orlando and 42 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Mar 6, 2026 at 4:01 AM#2
sarah.morrison said:
My prescriber mentioned this once, in a list, at speed, and I have been unable to find out since how worried I am supposed to be.

Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 7. Went to the ER — they checked lipase and amylase, both normal. Turned out to be a gallstone.

But I'm glad I went. The risk of pancreatitis, while small (<0.5%), is real. Don't try to tough out severe abdominal pain on a GLP-1 agonist. Get checked.

44 14stefan_berlin, Dr.EM_Chicago, pete_RVA and 41 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Mar 6, 2026 at 4:29 AM#3
mike_nyc said:
Pancreatitis scare with pancreatitis risk: had severe upper abdominal pain radiating to my back at week 7.

Lipase monitoring while on pancreatitis risk: my doctor checks lipase every 3 months given the theoretical pancreatitis risk. All readings have been normal:

  • Baseline: 45 U/L
  • Month 3: 31 U/L
  • Month 6: 33 U/L
  • Month 9: 33 U/L

Normal range is 0-160 U/L. While clinical pancreatitis is rare (<0.5%), I find peace of mind in regular monitoring. Worth asking your doctor about if you're on a GLP-1 long-term.

43 13stefan_berlin, Dr.EM_Chicago, pete_RVA and 40 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Mar 6, 2026 at 4:57 AM#4
sarah.morrison said:
My prescriber mentioned this once, in a list, at speed, and I have been unable to find out since how worried I am supposed to be.

Mine went the same way, slower. Posting only so the count is not one.

Last edited: Mar 6, 2026 at 6:57 AM
42 12amy_econ_NJ, bbq_ray_KC, oliver_london and 39 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Mar 6, 2026 at 7:30 AM#5

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Mar 6, 2026 at 10:30 AM
41 11LarryQC_SD, wanda_boise, NurseAsh_DET and 38 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register